A Cost-Benefit Analysis of Using Evidence of Effectiveness in Terms of Progression Free Survival in Making Reimbursement Decisions on New Cancer Therapies.

Autor:	Stevens, Warren, Philipson, Tomas1, Wu, Yanyu2, Chen, Connie3, Lakdawalla, Darius4
Zdroj:	Forum for Health Economics & Policy. Jan2014, Vol. 17 Issue 1, p21-52. 32p. 1 Diagram, 10 Charts, 2 Graphs.
Databáze:	Business Source Ultimate
Externí odkaz:	Zobrazit plný text záznamu